Order results by:
| Issue | Title | |
| Vol 8, No 3 (2012) | PHARMACOECONOMIC ASPECTS OF NICOTINE ADDICTION TREATMENT IN PATIENTS WITH ANGINA REQUIRING CARDIAC SURGERY | Abstract similar documents |
| A. V. Rudakova, M. S. Berezhnova | ||
| "... of varenicline is extremely high (in the analysis from the perspective of the health care system the cost ..." | ||
| Vol 14, No 1 (2018) | SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva | ||
| "... who continue to smoke. Smoking cessation is the most cost-effective strategy of cardiovascular disease ..." | ||
| Vol 15, No 1 (2019) | Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation | Abstract similar documents |
| S. R. Gilyarevskiy | ||
| "... of varenicline and evidence of its clinical efficacy and safety, including in patients with concomitant ..." | ||
| Vol 9, No 4 (2013) | VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... The problem of varenicline use in patients with cardiovascular diseases is discussed. Results ..." | ||
| Vol 7, No 3 (2011) | COSTS OF THE HEALTH CARE IN RUSSIA ASSOCIATED WITH SMOKING | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina | ||
| "... Aim. To analyze costs of health care in Russia associated with smoking in 2009. Material ..." | ||
| Vol 5, No 5 (2009) | THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES | Abstract similar documents |
| S. V. Malchikova, E. I. Tarlovskaya | ||
| "... Aim. To perform the comparative cost-efficacy analysis of various antihypertensive therapies ..." | ||
| Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
| A. V. Rudakova | ||
| "... Aim. To assess the cost-effectiveness of apixaban in the treatment and secondary prevention ..." | ||
| Vol 8, No 1 (2012) | ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL) | Abstract similar documents |
| M. A. Demidova, N. N. Kirilenko | ||
| "... Aim. To analyze the cost structure for pharmacotherapy of patients with stable angina (SA ..." | ||
| Vol 7, No 5 (2011) | ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva | ||
| "... . The study was performed based on methodology for Cost of Illness evaluation. Expenses associated with INR ..." | ||
| Vol 8, No 1 (2012) | CHANGES IN THE COSTS OF HYPERTENSIVE CRISIS THERAPY DUE TO OPTIMIZATION OF DRUG SUPPLY IN THE PRE-ADMISSION CARE | Abstract similar documents |
| N. I. Gaponova, N. F. Plavunov, V. L. Baratashvili | ||
| "... Aim. To assess the changes in the costs of treatment of patients with hypertensive crisis (HC ..." | ||
| Vol 6, No 4 (2010) | ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov | ||
| "... consultation. Costs associated with cardiovascular diseases and risk factors (medical care consumption ..." | ||
| Vol 9, No 4 (2013) | COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
| L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky | ||
| "... Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non ..." | ||
| Vol 4, No 3 (2008) | INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS) | Abstract similar documents |
| A. V. Kontsevaja, А. М. Kalinina, E. J. Spivak | ||
| "... Aim. To study influence of patient training in Health School on pharmacotherapy profile and cost ..." | ||
| Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Rudakova, V. A. Parfenov | ||
| "... in patients with NVAF in the Russian Federation. Aim. To evaluate the cost-effectiveness ratio of apixaban ..." | ||
| Vol 11, No 4 (2015) | EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. V. Rudakova, N. V. Lomakin | ||
| "... . To assess the cost-effectiveness of VerifyNow P2Y12 platelet reactivity testing in patients after ACS ..." | ||
| Vol 15, No 5 (2019) | Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Insurance in 2017 | Abstract similar documents |
| O. M. Drapkina, A. V. Kontsevaya, M. V. Sura, R. N. Shepel, L. M. Zhamalov | ||
| "... Aim. To assess the cost and importance of the vital and essential medicines for the treatment ..." | ||
| Vol 7, No 2 (2011) | COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE | Abstract similar documents |
| V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko | ||
| "... Aim. To evaluate clinical and cost effectiveness of different reperfusion strategies in myocardial ..." | ||
| Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... of any medical technology is economic value and cost-effectiveness. The objective of this review ..." | ||
| Vol 11, No 3 (2015) | PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT | Abstract similar documents |
| A. V. Rudakova | ||
| "... or oral anticoagulants that differ significantly in their efficacy, safety and cost of the therapy. Aim ..." | ||
| Vol 14, No 2 (2018) | PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
| S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov | ||
| "... of treatment and clinical practice results was built. Cost-effectiveness analysis was done by comparing two ..." | ||
| Vol 7, No 2 (2011) | SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina, I. E. Koltunov, R. G. Oganov | ||
| "... . Material and Methods. Direct costs and economic losses associated with ACS were estimated. The structure ..." | ||
| Vol 14, No 2 (2018) | ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 | Abstract PDF (Eng) similar documents |
| A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov | ||
| "... (RF) in 2016, including the direct costs and the economic losses caused by reduced productivity ..." | ||
| Vol 14, No 3 (2018) | ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, M. B. Khudyakov, O. I. Karpov, O. M. Drapkina | ||
| "... includes not only cost of its correction, but also the cost of treatment of diseases and complications ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| "... the cost-effectiveness of dabigatran etexilate versus warfarin prescribed in “real-world” settings from ..." | ||
| Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
| S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
| "... adherence, effects on surrogate and hard endpoints, and cost-effectiveness of the two statin regimens were ..." | ||
| Vol 17, No 5 (2021) | Pharmacogenetic Aspects of Postoperative Anesthesia with Ketoprofen in Cardiac Surgery Patients | Abstract similar documents |
| T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Z. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. А. Grishina, D. A. Sychev | ||
| "... послеоперационного обезболивания кетопрофеном у больных ИБС после кардиохирургических вмешательств. Материал и ..." | ||
| Vol 10, No 2 (2014) | PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM | Abstract PDF (Eng) similar documents |
| A. M. Kalinina, A. V. Kontsevaya | ||
| "... . Cost-effectiveness of primary prevention, including the one of MI, has been conclusively showed ..." | ||
| Vol 7, No 4 (2011) | VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova | ||
| "... with arterial hypertension (HT) of 1-2 degrees, and to evaluate the cost effectiveness of original drug ..." | ||
| Vol 5, No 3 (2009) | CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov | ||
| "... (with estimation of the total costs, costs for one studied person and costs for revealing of one person needed ..." | ||
| Vol 9, No 1 (2013) | PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review | Abstract similar documents |
| T. S. Romanenko, A. V. Kontsevaya, S. V. Fitilev | ||
| "... therapy, conducted during the last decades inRussia. Despite the increased interest to the issue of cost ..." | ||
| Vol 11, No 6 (2015) | Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events | Abstract similar documents |
| O. V. Shatalova | ||
| "... of the health care system. The cost analysis, "cost-effectiveness" analysis, "impact on the budget” analysis ..." | ||
| Vol 13, No 1 (2017) | CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova | ||
| "... Aim. To compare cost-effectiveness of the use of direct factor Xa inhibitors rivaroxaban ..." | ||
| Vol 3, No 4 (2007) | THE ALGORITHMIC MODEL OF LABORATORY DIAGNOSTICS OPTIMIZATION | Abstract similar documents |
| G. I. Nazarenko, O. V. Andropova | ||
| "... of algorithmic approach is able to optimize diagnostics and its costs. Various algorithmic models, their features ..." | ||
| Vol 12, No 1 (2016) | Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease | Abstract similar documents |
| E. I. Tarlovskaya, T. I. Chudinovskikh | ||
| "... Aim. To compare the efficacy and cost/effectiveness ratio of the original and generic bisoprolol ..." | ||
| Vol 17, No 4 (2021) | Evaluation of the Influence of CYP2C9* 2, CYP2C9*3 Gene Polymorphisms on the Efficacy and Safety of Postoperative Analgesia with Ketoprofen in Patients after Cardiac Surgery | Abstract similar documents |
| T. E. Morozova, D. A. Shatsky, N. V. Shikh, E. V. Shikh, T. B. Andrushchyshina, M. V. Lukina, A. A. Kachanova, Zh. A. Sozaeva, G. N. Shuev, N. P. Denisenko, E. A. Grishina, D. A. Sychev | ||
| "... в послеоперационном периоде после кардиохирургических вмешательств. Материал и методы. В ..." | ||
| Vol 9, No 1 (2013) | CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE | Abstract similar documents |
| M. I. Shupina, O. Ju. Korennova, E. N. Loginova | ||
| "... Aim. To study clinical and cost effectiveness of training of young patients with arterial ..." | ||
| Vol 8, No 2 (2012) | PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION | Abstract similar documents |
| E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva | ||
| "... (LVMI) were considered. Cost-effectiveness method of analysis was used. Results. In V/A group 75 ..." | ||
| Vol 7, No 1 (2011) | THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY | Abstract similar documents |
| S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich | ||
| "... Aim. Тo compare the cost-effectiveness of antihypertensive therapy based on a generic and original ..." | ||
| Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
| "... in 2016, including direct costs of the health care system and indirect economic losses due to premature ..." | ||
| Vol 10, No 4 (2014) | RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA | Abstract similar documents |
| T. Vekov | ||
| "... фармацевтических компаний при прохождении процедуры на включение в список разрешенных лекарств, затраты на которые ..." | ||
| Vol 6, No 4 (2010) | PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov | ||
| "... Aim. To perform cost-effectiveness analysis of 24 weeks antihypertensive therapy based ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... the results of the lipid profile. To perform a pharmacoeconomic analysis and evaluate the “cost/effectiveness ..." | ||
| Vol 10, No 4 (2014) | PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE | Abstract similar documents |
| E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova | ||
| "... without ischemic heart disease (n=56) were included into the study. Blood pressure (BP) dynamics and cost ..." | ||
| Vol 16, No 3 (2020) | Economic Burden of Hypertension in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. O. Myrzamatova, D. K. Mukaneeva, M. B. Khudyakov, O. M. Drapkina | ||
| "... in the RF in 2016 including direct costs and economic losses caused by decreased labor efficiency. Material ..." | ||
| Vol 13, No 2 (2017) | THESES OF PSYCHOSOMATIC MEDICINE | Abstract similar documents |
| F. I. Belyalov | ||
| "... , increase healthcare costs. Antidepressants decrease severity of anxiety and depression, as well as diminish ..." | ||
| Vol 1, No 1 (2005) | ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES | Abstract similar documents |
| V. V. Yakusevich | ||
| "... it possible to decrease the costs of treatment. From the other side with the advent of big number of copies ..." | ||
| Vol 11, No 3 (2015) | ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... of them the cost of anticoagulation therapy was determined on the basis of the average weighted prices ..." | ||
| Vol 7, No 5 (2011) | COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... , creatine phosphokinase were evaluated every 4 weeks. Cost-effectiveness ratio was calculated. Results. 11 ..." | ||
| Vol 18, No 2 (2022) | The problem of choice: original drug or generic? Emphasis on rosuvastatin | Abstract similar documents |
| O. A. Polyakova, O. D. Ostroumova | ||
| "... to a significant increase in the cost of medical care in the field of public health. The transition from original ..." | ||
| Vol 6, No 6 (2010) | EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER) | Abstract similar documents |
| T. A. Istomina, E. V. Serdechnaya, L. A. Kulminskaya, B. A. Tatarskiy, E. V. Kazakevich, V. L. Lipskiy, S. I. Martyushov | ||
| "... ), and amiodarone 600-800 mg daily. The cost/effectiveness ratio (CER) was estimated. This ratio shows the cost ..." | ||
| Vol 7, No 5 (2011) | ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina | ||
| "... 516 772.42 RUR for every 1 000 patients. It would reduce the total costs per patient during 10 years ..." | ||
| Vol 3, No 5 (2007) | CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich | ||
| "... Amlorus and Norvasc, respectively. Cost of Amlorus therapy per patient was 221 rbl/month in comparison ..." | ||
| Vol 8, No 2 (2012) | COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| O. P. Bobrova, M. M. Petrova | ||
| "... of cost minimization analysis. Results. Original enalapril dose necessary to achieve the target blood ..." | ||
| Vol 4, No 5 (2008) | CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| M. V. Soura | ||
| "... ’s comparative cost analysis on metoprolol tartrate (Betaloc) and metoprolol succinate (Betaloc ZOK) usage ..." | ||
| Vol 6, No 4 (2010) | DIAGNOSTICS AND TREATMENT OF MITRAL VALVE PROLAPSE | Abstract similar documents |
| D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko | ||
| "... кардиохирургической коррекции заболевания. Методом выбора в этих случаях является проведение пластики митрального ..." | ||
| Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
| A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
| "... » group direct cost for inpatient AC therapy was significantly higher than in «adherent» group 4041 rubles ..." | ||
| Vol 5, No 4 (2009) | CLINICO-ECONOMICAL ANALYSIS OF THE TREATMENT EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES | Abstract similar documents |
| L. A. Haisheva, S. V. Shlyk, T. Y. Bykovskaya | ||
| "... was performed according to “cost-efficacy” approach at the end of 3 month therapy. Results. About 50 ..." | ||
| Vol 19, No 1 (2023) | Effect of Antibiotic Therapy on the Sensitivity of Etiological Diagnostic Methods in Patients with Infective Endocarditis after Surgery | Abstract similar documents |
| E. O. Kotova, A. Yu. Moiseeva, Zh. D. Kobalava, E. A. Domonova, A. S. Pisaruk, O. Yu. Silveistrova, P. V. Kakhktsyan, V. V. Vladimirov | ||
| "... поступления в кардиохирургический стационар, а также параллельные одномоментные МБИ и ПЦР-исследование крови ..." | ||
| Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
| M. M. Batiushin | ||
| "... . It should be remembered that the cost of late diagnosis of CKD is a reduction in life expectancy, primarily ..." | ||
| Vol 19, No 5 (2023) | White coat effect in patients with hypertension | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov, D. N. Antipushina, E. V. Platonova | ||
| "... to additional prescription of antihypertensive drugs, increasing costs and side effects. To identify WCE ..." | ||
| Vol 16, No 1 (2020) | Deprescribing Antihypertensive Drugs in Patients of Older Age Groups | Abstract similar documents |
| O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev | ||
| "... and reduces the economic cost of treatment. Therefore, deprescribing of antihypertensive drugs can be used ..." | ||
| Vol 15, No 2 (2019) | Cardiovascular medicine prices as an indicator of access to medicines and their rational use | Abstract similar documents |
| C M. Razzakova, L. E. Ziganshina | ||
| "... procurement prices of these medicines in hospitals. Also we performed pharmacoeconomic cost-minimisation ..." | ||
| Vol 2, No 3 (2006) | APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY | Abstract similar documents |
| S. V. Nedogoda | ||
| "... применение у кардиохирургических пациентов. ..." | ||
| Vol 16, No 6 (2020) | Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level | Abstract similar documents |
| C. M. Razzakova, L. E. Ziganshina | ||
| "... as performed pharmacoeconomic cost-minimization analysis for arterial hypertension pharmacotherapy in 2018 ..." | ||
| Vol 16, No 2 (2020) | Infectious Endocarditis in the Elderly – Comparative Study of Clinical Features, Course and Outcomes | Abstract PDF (Eng) similar documents |
| N. S. Chipigina, N. Yu. Karpova, D. A. Anichkov, T. B. Kondratieva | ||
| "... проводилось кардиохирургическое лечение (8% и 24,8%, соответственно; р<0,05); внутрибольничная летальность ..." | ||
| Vol 21, No 1 (2025) | Cytokine profile of surgical patients with infective endocarditis | Abstract similar documents |
| E. O. Kotova, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, T. A. Gusarova, J. I. Babukhina, P. V. Kakhktsyan, T. K. Fatkhudinov, Z. D. Kobalava | ||
| "... 2015 г.) и 24 пациента с пороками сердца без ИЭ, госпитализированных для кардиохирургического лечения ..." | ||
| Vol 9, No 3 (2013) | ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING | Abstract similar documents |
| N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova | ||
| "... 1000 patients. It would reduce the total costs per patient during 10 years. V/A therapy is able to save ..." | ||
| Vol 16, No 1 (2020) | The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation | Abstract similar documents |
| A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva | ||
| "... лет (82,7±3,4 лет). Кардиохирургическое вмешательство ранее выполнено у 27,6% пациентов. Все пациенты ..." | ||
| Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
| L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
| "... , treatment costs and safety). The place of ACE inhibitors and ARB in modern therapy of cardiovascular ..." | ||
| Vol 8, No 2 (2012) | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya | ||
| "... to treatment, induces additional costs or may be a reason of new side effects. Additional (to standard therapy ..." | ||
| Vol 13, No 1 (2017) | MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE | Abstract similar documents |
| N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya | ||
| "... затрат сил и времени для самообразования. Цель обзора – в краткой форме помочь практикующим врачам ..." | ||
| Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
| "... is easy to follow and well accepted by patients despite of twice-daily dosing regimen. Healthcare cost ..." | ||
| Vol 10, No 2 (2014) | EVALUATION OF ATRIAL CONTRACTILE FUNCTION DISORDERS AND FIBROSIS AS PREDICTORS OF CHRONIC HEART FAILURE | Abstract similar documents |
| O. M. Drapkina, E. V. Cherkunova | ||
| "... Chronic heart failure (CHF) is a major health problem in many countries now, and the cost ..." | ||
| Vol 14, No 2 (2018) | RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM MINIMIZATION OF EXPENSES TO EFFECTIVE MANAGEMENT | Abstract similar documents |
| N. A. Nikolayev, Yu. P. Skirdenko, S. S. Bunova, A. V. Ershov | ||
| "... than the class or cost of medicines, the original or generic nature of the drugs, or their dosage ..." | ||
| Vol 4, No 1 (2008) | PHARMACOEPIDEMIOLOGICAL STUDY OF DOCTORS HABITS IN PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN TOWN OF OREL | Abstract similar documents |
| G. I. Shvets, S. V. Povetkin | ||
| "... % of doctors prescribed pharmacotherapy, which cost 100 to 500 rubles per months. Not rational combinations ..." | ||
| Vol 7, No 6 (2011) | COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... ) and microalbuminuria (MAU) and to calculate cost-effectiveness ratio (CER). Material and methods. Patients (n=75 ..." | ||
| Vol 14, No 2 (2018) | WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY | Abstract similar documents |
| R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin | ||
| "... . The main reason limiting the widespread use of NOACs is the high cost of these drugs. Conclusion ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... analyzing the cost of drugs in licensed pharmacies, it was found that drugs containing furosemide ..." | ||
| Vol 6, No 2 (2010) | EVALUATION BY PRACTICING DOCTORS OF THE MODERN PHARMACOTHERAPY POSSIBILITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE. RESULTS OF DOCTOR INTERVIEW IN MOSCOW AND VORONEZH | Abstract similar documents |
| S. Yu. Martsevich, L. Yu. Drozdova, Yu. V. Lukina, N. V. Sinyagina, T. G. Kheliya | ||
| "... , respectively, considered high cost of statins as the main limit for its implementation. Conclusion. On one ..." | ||
| Vol 9, No 3 (2013) | NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES | Abstract similar documents |
| M. G. Gambaryan | ||
| "... of cardiorespiratory diseases. Smoking cessation is the most cost-effective measure for prevention of cardiovascular ..." | ||
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| "... taken to correct and control lipid metabolism disorders were insignificant within 3 years. High costs ..." | ||
| Vol 17, No 1 (2021) | Myocardial Infarction Complicated by Ischemic Stroke: Risk Factors, Prognosis, Unresolved Problems and Possible Methods of Prevention | Abstract similar documents |
| M. V. Zykov, V. V. Butsev, R. R. Suleymanov | ||
| "... in the cost of treatment. So, it is extremely important to detect thrombosis of the left ventricular cavity ..." | ||
| Vol 15, No 3 (2019) | Medication Adherence: does Patient Participation in Randomized Clinical Trials Affect on it? | Abstract similar documents |
| N. O. Vasyukova, Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. I. Zvonareva | ||
| "... of the patient can significantly worsen the effectiveness of treatment and leads to increased health care costs ..." | ||
| Vol 20, No 4 (2024) | Clinical application of clinical decision support systems in the management of patients with atrial fibrillation | Abstract similar documents |
| A. V. Ponomarenko, A. D. Gavrilko, A. A. Gartung, M. S. Poliakova, A. A. Oganesyan, K. S. Benimetskaya, D. V. Losik, S. V. Shalaev | ||
| "... to optimize patient treatment, reduce financial costs, but also to improve long-term outcomes. The volume ..." | ||
| Vol 12, No 3 (2016) | LOW ADHERENCE TO TREATMENT AFTER MYOCARDIAL INFARCTION: CAUSES AND WAYS OF ADJUSTMENT CONSIDERING PSYCHO-EMOTIONAL STATE OF PATIENTS | Abstract PDF (Eng) similar documents |
| E. A. Kuzheleva, K. N. Borel', A. A. Garganeeva | ||
| "... 's prescriptions (14%); a large number of prescribed drugs (12%); high cost of drugs (4%). The structure ..." | ||
| Vol 11, No 4 (2015) | MULTI-CHANNEL VOLUME SPHYGMOGRAPHY IN CARDIOANGIOLOGICAL SCREENING OF THE ADULT POPULATION | Abstract similar documents |
| R. A. Khokhlov, N. I. Ostroushko, A. E. Gaydashev, D. V. Kirsanov, N. M. Akhmedzhanov | ||
| "... be regarded as the basis for low-cost and efficient system of cardioangiological screening. ..." | ||
| Vol 16, No 3 (2020) | Treatment of Hypertension: Is There a Place for Personalization of the Approach in Modern Recommendations? | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, Yu. N. Rodionova | ||
| "... , reduction in the cost of the drug and the number of tablets. As an example, a highly effective single-pill ..." | ||
| Vol 4, No 3 (2008) | ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES | Abstract similar documents |
| E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich | ||
| "... carvedilol has lower cost of treatment than this in original carvedilol. ..." | ||
| Vol 9, No 5 (2013) | ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) | Abstract PDF (Eng) similar documents |
| Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels | ||
| "... the importance of lowering drug costs. 11 patients of 272 respondents demanded more care from their doctor; 4 ..." | ||
| Vol 16, No 2 (2020) | Clinical profile and drug therapy of outpatients with arterial hypertension | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, V. M. Bakhtin, M. A. Shambatov | ||
| "... visit without additional costs. Compliance with the current antihypertensive therapy guidelines allows ..." | ||
| 1 - 91 of 91 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
